Rejected from Nature Protocols? Where to Submit Next
A post-rejection routing guide for Nature Protocols authors: when to rebuild the presubmission enquiry, when to move to STAR Protocols, Bio-protocol, Current Protocols, JoVE, methods.io, or a methods journal, and when the original research paper is the real owner.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: If you were rejected from Nature Protocols, first decide whether the decision rejected the protocol concept, the protocol maturity, or the journal tier. Authors searching "rejected from nature protocols" usually need a routing decision, not another formatting checklist. Nature Protocols predominantly publishes Protocols, Protocol Updates, Protocol Extensions, and technique-related article types based on published primary research; it is not just a home for any useful method.
If the protocol is mature but too narrow or not selective enough for Nature Protocols, consider STAR Protocols, Bio-protocol, Current Protocols, JoVE, methods.io, or a specialist society protocol venue. If the work is still a new method story rather than a reusable protocol, consider Nature Methods, Cell Reports Methods, Genome Biology, Bioinformatics, Analytical Chemistry, or a field-specific methods journal. Fix first if the rejection questioned outside-lab reproducibility, procedural completeness, troubleshooting, or evidence that the method is already proven.
Before you move, run a Nature Protocols rejection routing check to separate a venue problem from a protocol-readiness problem. If you are still deciding whether the original target was realistic, read the Nature Protocols submission guide, Nature Protocols desk-rejection guide, Nature Protocols under-consideration guide, and Nature Protocols review-time guide.
Method note and current Nature Protocols facts
This page was built from current Nature Portfolio, Cell Press, Wiley, JoVE, and protocol-journal source pages, plus Manusights pre-submission reviews of protocol manuscripts. Last reviewed: July 16, 2026.
Nature Portfolio's current Nature Protocols aims page says the journal publishes secondary research articles, predominantly Protocols, including Protocol Updates and Protocol Extensions, plus technique-related Reviews, Perspectives, Correspondences, Matters Arising, Commentaries, and Consensus Statements. The journal information page repeats that these article types are based on published primary research papers.
The current Nature Protocols preparation page describes a presubmission enquiry process. Authors start by clicking the Submit Presubmission Enquiry link and uploading the requested summary and documents; an editor then decides whether the proposed protocol is interesting enough to consider. Nature Protocols reviewer guidance also says some presubmission enquiries are sent for informal review so authors are only asked to prepare full versions of protocols that appear suitable and sufficiently interesting.
The current editors page lists Melanie Clyne, PhD as Chief Editor and says Nature Protocols has no external editorial board; editorial decisions are made by dedicated professional editors with relevant research and editorial backgrounds. The submission system used by the existing Manusights Nature Protocols guide is https://mts-nprot.nature.com. Recent Nature Protocols DOI patterns include 10.1038/s41596-023-00945-2, 10.1038/s41596-024-01023-7, 10.1038/s41596-024-01156-9, and the 2026 editorial DOI 10.1038/s41596-026-01377-3. These details matter after rejection because the next route should be chosen by article type and execution value, not by prestige proximity.
Those facts define the post-rejection decision. A Nature Protocols rejection may mean:
- the proposed protocol was not suitable for the journal's selective Protocol format
- the method was not yet proven enough in published or accepted primary work
- the audience was too narrow for Nature Protocols
- the paper lacked enough procedural value beyond the original research article
- the technique was better served by a video, shorter protocol, community protocol, or methods-journal article
The next target depends on which of those signals appeared in the decision letter.
First, classify the rejection
Nature Protocols rejections split into route-now and fix-first cases. Route-now means the work can be published elsewhere with a changed article shape. Fix-first means the next venue will see the same maturity or reproducibility problem.
Rejection signal | What it usually means | Best next action |
|---|---|---|
"Not suitable for Nature Protocols" | The protocol may be valid but not selective enough | Route to STAR Protocols, Bio-protocol, Current Protocols, JoVE, or a specialist venue |
"Too preliminary" | The workflow is still a method, not a stable protocol | Publish or strengthen the primary method paper first |
"Limited broad interest" | The audience is narrower than Nature Protocols wants | Choose a field-specific protocol or methods journal |
"Insufficient reproducibility detail" | Outside labs may not be able to execute it | Fix materials, timing, critical steps, troubleshooting, and expected outcomes before resubmission |
"Not enough beyond the original paper" | The manuscript reads like an expanded methods section | Add protocol-specific user value or route to a community protocol venue |
"Better suited to video demonstration" | Hand technique or setup is central | Consider JoVE or a video-supported protocol format |
The highest-leverage question is simple: did Nature Protocols reject the venue fit, or did it reject the protocol as a protocol?
Best journals and platforms to submit next after a Nature Protocols rejection
Next venue | Best fit after Nature Protocols rejection | Do not choose it if |
|---|---|---|
STAR Protocols | Complete, reproducible experimental protocols where usability is the main value | The workflow is not yet stable or cannot follow a structured protocol template |
Bio-protocol | Broad biological protocols needing practical dissemination rather than Nature Portfolio selectivity | The work needs a high-selectivity editorial brand more than user adoption |
Current Protocols | Mature life-science procedures that fit Wiley's protocol collection and practical overview style | The manuscript is a research article or primarily claims novelty |
JoVE | Methods where video demonstration improves reproducibility, training, or adoption | The protocol is mainly computational, text-based, or does not benefit from filmed execution |
methods.io or community protocol repositories | Fast dissemination, lab standard operating procedures, or protocol sharing tied to published work | You need a peer-reviewed journal article as the main output |
Cell Reports Methods | A method-development paper with validation and applications, not just a protocol | The manuscript is only a step-by-step procedure |
Nature Methods | A genuinely novel method with broad life-science impact and rigorous benchmarking | Nature Protocols rejected it because the method is mature but narrow |
Field methods journal | Specialist procedures for microscopy, sequencing, proteomics, imaging, chemistry, animal models, or computation | The protocol has broad cross-field value and a top protocol venue remains realistic |
This route map prevents the common mistake after Nature Protocols rejection: sending the same presubmission summary to another venue without changing whether the article is a protocol, a method paper, or a community resource.
What to do in the next 72 hours
Do not start by changing citation style. Diagnose the rejected file first.
Time window | Action | Output |
|---|---|---|
First 24 hours | Mark each decision-letter sentence as concept fit, maturity, audience breadth, reproducibility, procedural detail, video need, or methods-journal fit | One dominant rejection category |
Hours 24 to 48 | Choose protocol venue, video venue, methods journal, or community protocol repository | One primary target with two backups |
Hours 48 to 72 | Rewrite the abstract, protocol structure, troubleshooting table, expected-outcomes section, and cover-letter paragraph for the chosen route | A package that no longer reads like a rejected Nature Protocols enquiry |
If the dominant issue is selective venue fit, resubmission can be fast. If the dominant issue is protocol maturity, more writing will not solve it; the method needs stronger validation or clearer outside-lab execution logic.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
In our pre-submission review work on Nature Protocols submissions, four rejection patterns decide the next move
In our pre-submission review work on Nature Protocols submissions, the main decision fork is whether the manuscript is already a reusable protocol product or still a research method looking for a protocols label. We look at the file the way a protocol user would: can a competent outside lab execute this next week without asking the originating lab for missing reagent choices, timing windows, instrument settings, failure-state explanations, or judgment calls?
A useful workflow that is not yet a protocol product. This is the fastest rejection pattern. The method may be clever, published, and important, but Nature Protocols asks whether another lab can execute it from the article. If reagents, timing, equipment settings, critical steps, expected outcomes, and troubleshooting are still implicit, fix first.
A protocol too close to the original methods section. A Nature Protocols article needs to add procedural value beyond the primary paper. A longer methods section is not enough. The new file should help users decide what to do when the experiment fails, which substitutions are safe, what results should look like, and how the method adapts to related use cases.
A narrow lab-specific procedure. Some protocols are valuable but not broad enough for Nature Protocols. A specialized antibody staining variation, organism-specific handling tweak, one-instrument pipeline, local clinical workflow, or one-lab analysis script may fit Bio-protocol, Current Protocols, JoVE, a specialist journal, or a repository better.
A method paper miscast as a protocol. If the rejected manuscript is still arguing that the method is new, better, or biologically revealing, the next venue may be Nature Methods, Cell Reports Methods, Genome Biology, Bioinformatics, Analytical Chemistry, or a discipline methods journal. Do not force a research contribution into a step-by-step protocol shape.
The non-obvious signal is the troubleshooting table. In strong rejected-to-next-route cases, the troubleshooting table is not decoration; it shows whether the authors understand the protocol as a product. If every problem has the same answer, such as "repeat the experiment" or "optimize conditions," the file is not ready for another selective protocol journal. If the table distinguishes reagent degradation, sample-preparation failure, timing drift, instrument calibration, cell-state variation, batch effects, and analysis thresholds, the protocol may simply need a better-fit venue.
We also check whether the protocol's user is real. "Useful to many labs" is too vague. A better next submission identifies the exact user: a microscopy core onboarding new users, a stem-cell lab adapting a differentiation workflow, a proteomics group standardizing sample preparation, a computational biology team reproducing an analysis pipeline, or a clinical translational lab validating a specimen workflow. That user definition often decides whether STAR Protocols, Bio-protocol, JoVE, Current Protocols, or a methods journal is the honest route.
We see the strongest recoveries when authors stop defending the rejected Nature Protocols target and rebuild the package around the next reader's job. For STAR Protocols, that means a template-ready protocol with reproducibility and usability foregrounded. For JoVE, it means a filming plan that shows the manipulations a written protocol cannot teach. For a methods journal, it means benchmark figures, controls, statistical comparisons, and application data. That is the non-obvious post-rejection move: the next venue is not a lower-prestige copy of Nature Protocols; it is a different product contract.
The practical rule is: mature protocols should move to a protocol venue; immature methods should become methods papers or be validated further.
When STAR Protocols is the right next target
STAR Protocols is often the cleanest next target after a Nature Protocols rejection when the manuscript is complete and reproducible but does not need Nature Portfolio selectivity. Cell Press describes STAR Protocols as an open-access journal publishing complete, authoritative, and consistent instructions for conducting experiments, with usability and reproducibility as primary publication criteria.
Choose STAR Protocols when:
- the experiment can be described as a complete, step-by-step protocol
- usability and reproducibility are the strongest claims
- the workflow has enough prior validation to be useful now
- the manuscript can follow the STAR Protocols article template
- the expected users are researchers who need to execute the procedure, not evaluate a new claim
Pause before choosing it when:
- the method still needs benchmarking as a research contribution
- the protocol cannot yet be reproduced outside the originating lab
- the main output is a computational tool, not an experimental procedure
- video demonstration is central to adoption
The rewrite should make the paper feel like a user manual, not like a Nature Protocols presubmission pitch with the title changed.
When JoVE is the right next target
JoVE is worth considering when the limiting information is visual. If success depends on hand movements, instrument positioning, animal handling, surgical approach, cell manipulation, sample appearance, microscope setup, or subtle timing, a video article can carry information that text misses.
Choose JoVE when:
- the method is hard to learn from text alone
- visual demonstration would reduce training time or error rate
- adoption by other labs is a core goal
- the procedure benefits from filmed setup, execution, and expected appearance
- the authors can support filming or produce the necessary video material
Do not choose JoVE just because Nature Protocols declined. If the protocol is mostly computational, reagent selection, decision logic, or analysis code, a text protocol or methods venue is usually a better fit.
When to route to a methods journal instead
If the Nature Protocols rejection says the work is not yet a proven protocol, do not fight the category. Route the paper by its actual contribution.
Manuscript center | Better route | Why |
|---|---|---|
New experimental method with broad life-science impact | Nature Methods | The novelty claim is still methodological |
Applied platform or technology with biological utility | Nature Biotechnology or Cell Reports Methods | The method and application both matter |
Computational pipeline or software workflow | Genome Biology, Bioinformatics, NAR, or field computational journal | The core value is algorithmic or software utility |
Analytical chemistry, mass spec, imaging, or sensor method | Analytical Chemistry, ACS Measurement Science Au, or specialist journal | The methods audience owns the validation standards |
Discipline-specific lab protocol | Specialist society journal or field protocol venue | The users are concentrated in one community |
Community SOP tied to an already published method | methods.io, protocols.io-style repository, or lab protocol resource | Speed and discoverability matter more than journal selectivity |
The cover letter should change accordingly. Do not describe a method-development paper as a protocol unless the article is truly ready to function as one.
Reframe the next cover letter by rejection reason
The next cover letter should not sound like a lightly edited Nature Protocols enquiry.
For STAR Protocols:
This manuscript provides a complete, reproducible protocol with step-by-step instructions, expected outcomes, troubleshooting guidance, and practical notes that allow researchers to implement the workflow in their own laboratories.
For Bio-protocol:
This protocol translates an established biological method into an accessible procedural resource for researchers who need practical implementation detail beyond the original research article.
For Current Protocols:
This article provides a mature life-science procedure with practical overview, materials, timing, and decision points suitable for researchers adopting the technique in routine laboratory work.
For JoVE:
This method benefits from visual demonstration because success depends on execution details that are difficult to capture fully in text, including setup, handling, timing, and expected visual outcomes.
For a methods journal:
This manuscript presents and validates a methodological advance, with benchmarking and applications showing where the method improves on existing alternatives.
If the paragraph sounds dishonest, the target is wrong or the manuscript needs more work.
Submit-now versus fix-first matrix
Situation after Nature Protocols rejection | Submit elsewhere now | Fix first |
|---|---|---|
Rejection says the protocol is valid but not a Nature Protocols fit | Yes, to a protocol venue with the right scope | Reformat and retarget the article shape |
Rejection says the workflow is too new | No | Add validation, adoption evidence, or primary-publication support |
Rejection says audience is too narrow | Maybe, to a specialist protocol venue | Broaden only if a broad protocol venue remains the goal |
Rejection says procedural detail is insufficient | No | Add materials, timing, critical steps, troubleshooting, and expected outcomes |
Rejection says the manuscript adds little beyond the original paper | No | Add user-value sections or choose a repository |
Rejection says visual demonstration would help | Maybe, to JoVE | Build the video plan and execution script |
Transfer or redirect option appears | Maybe | Accept only if the target owns the manuscript's real center |
Most failed cascades come from preserving the rejected manuscript's category confusion.
Before you resubmit
Run this checklist before uploading the next version:
- [ ] The manuscript is clearly either a protocol, a method paper, a video article, or a community protocol resource.
- [ ] The abstract says what users can execute, not only why the method is interesting.
- [ ] The protocol has materials, equipment, setup, timing, critical steps, pause points, expected results, and troubleshooting.
- [ ] The method has already been proven in published, accepted, or otherwise defensible primary work.
- [ ] The target venue's article type matches the manuscript's true center.
- [ ] Figures and tables help users execute the workflow, not just explain the original discovery.
- [ ] The cover letter is written for the new venue's audience, not for Nature Protocols.
- [ ] Any Nature Portfolio transfer or redirect is evaluated as a fit suggestion, not an automatic path.
Before submitting elsewhere, run a Nature Protocols resubmission readiness check to catch the maturity, reproducibility, and protocol-user defects that often follow rejected manuscripts to the next journal.
Frequently asked questions
Choose the next venue from the rejection reason. If the protocol is usable and reproducible but not selective enough for Nature Protocols, consider STAR Protocols, Bio-protocol, Current Protocols, JoVE, methods.io, or a society protocol venue. If the work is still a new method rather than a mature protocol, route to Nature Methods, Cell Reports Methods, Genome Biology, Bioinformatics, Analytical Chemistry, or a field methods journal instead.
Usually no. Nature Protocols has a distinctive presubmission-enquiry and full Protocol structure. STAR Protocols, Bio-protocol, Current Protocols, JoVE, and methods journals each want different article shapes, so the abstract, protocol architecture, troubleshooting detail, figures, and cover letter should change before resubmission.
The most common pattern is a useful workflow that is not yet a mature protocol product for other labs. It may be too new, too narrow, insufficiently validated outside the originating lab, or too close to the methods section of the original research paper.
Often yes if the protocol is complete, usable, reproducible, and experiment-focused but does not need the more selective Nature Protocols lane. STAR Protocols is a strong next target when usability and reproducibility are clear and the manuscript can follow the Cell Press protocol template.
Consider JoVE when the method depends on visual execution, hand position, animal handling, instrument setup, sample manipulation, or training value that text alone does not capture. If the protocol is mostly decision logic, computation, or reagent tables, a text protocol venue may be stronger.
Sources
- Sources used for this routing guide include current Nature Portfolio, Cell Press, Wiley, JoVE, and protocol-publication pages checked on July 16, 2026.
- 1. Nature Protocols aims and scope, Nature Portfolio.
- 2. Nature Protocols preparing your submission, Nature Portfolio.
- 3. Nature Protocols journal information, Nature Portfolio.
- 4. Nature Protocols reviewer guidance, Nature Portfolio.
- 5. Nature Protocols editors, Nature Portfolio.
- 6. Celebrating 20 years of Nature Protocols, Nature Protocols.
- 7. STAR Protocols aims and scope, Cell Press.
- 8. STAR Protocols information for authors, Cell Press.
- 9. Current Protocols author guidelines, Wiley.
- 10. JoVE publishing process, JoVE.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Your manuscript is never used to train any model.
Where to go next
Same journal, next question
- Nature Protocols Submission Guide
- How to Avoid Desk Rejection at Nature Protocols (2026)
- Nature Protocols Submission Process: What Happens After Upload
- Nature Protocols Review Time: What Authors Can Actually Expect
- Nature Protocols Impact Factor 2026: 18.4, Q1, Rank 2/85
- Nature Protocols 'Under Consideration': What the Status Means